Immix Biopharma Shares Surge 61% On Positive Rates for Multiple Myeloma, AL Amyloidosis Drug

Retrieved on: 2022-12-14 17:11:33

Tags for this article:

Click the tags to see associated articles and topics

Immix Biopharma Shares Surge 61% On Positive Rates for Multiple Myeloma, AL Amyloidosis Drug. View article details on hiswai:

Excerpt

By Kathryn Hardison Shares of Immix Biopharma Inc. surged 61% to $2.35 Wednesday after the company shared positive trial response rates for its...

Article found on: www.marketwatch.com